Accessibility
Animation
Accessibility
AACC 2019 -- The requirements from IFCC (International Federation of Clinical Chemistry) to qualify a cardiac Troponin assay to be qualified as a high sensitive assay are that the, Assay must have analytical imprecision of 10% at the 99th percentile, Assay must be able to measure cTn above the LOD in >50% of the patients and the 99th percentile should be established with 300 M and 300 F. In this study, we evaluated the performance of two FDA approved Troponin HS assays (Siemens Centaur and Beckman DxI Assays) and two CE marked Troponin HS assays (Abbott Architect and Fujirebio Lumipulse Assays).